Acuta Capital Partners’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Acuta Capital Partners’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-82,552	Closed	-$669K	–	59
2015 Q4	$669K	Sell	82,552 -9,845	-11%	-$82.1K	0.32%	46
2015 Q3	$780K	Buy	+92,397	New	+$851K	0.45%	48
2015 Q2	–	Sell	-237,600	Closed	-$2.2M	–	64
2015 Q1	$2.2M	Sell	237,600 -65,877	-22%	-$631K	1.85%	18
2014 Q4	$2.81M	Buy	+303,477	New	+$2.55M	1.9%	14

Other funds holding CORV

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

AIS

AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acuta Capital Partners's CORV Position: Q1 2016 in Review

Acuta Capital Partners sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2016, closing a stake of 82,552 shares — an estimated $669K sold.

Acuta Capital Partners first reported a position in CORV in Q4 2014 and held it in 4 quarters. The position peaked at $2.81M in Q4 2014. 26 funds tracked by Wall St. Rank hold CORV as of Q1 2016.

Acuta Capital Partners reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2016 after selling out during the quarter.
Acuta Capital Partners sold 82,552 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2016, an estimated $669K.
Acuta Capital Partners first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2014 and held it in 4 quarters.
Acuta Capital Partners's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $2.81M in Q4 2014.
26 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2016.

Based on Acuta Capital Partners's 13F filing for Q1 2016, filed 13 May 2016.